Trial Profile
Contrasting the Brain Effects of Risperidone and Invega With fMRI and PET Scanning.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary) ; Risperidone (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- 06 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 20 Jul 2009 New trial record